One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces

Acta Biochimica Et Biophysica Sinica
He HuangYinhua Lu

Abstract

The RNA-guided DNA editing technology CRISPRs (clustered regularly interspaced short palindromic repeats)/Cas9 had been used to introduce double-stranded breaks into genomes and to direct subsequent site-specific insertions/deletions or the replacement of genetic material in bacteria, such as Escherichia coli, Streptococcus pneumonia, and Lactobacillus reuteri. In this study, we established a high-efficiency CRISPR/Cas9 genome editing plasmid pKCcas9dO for use in Streptomyces genetic manipulation, which comprises a target-specific guide RNA, a codon-optimized cas9, and two homology-directed repair templates. By delivering pKCcas9dO series editing plasmids into the model strain Streptomyces coelicolor M145, through one-step intergeneric transfer, we achieved the genome editing at different levels with high efficiencies of 60%-100%, including single gene deletion, such as actII-orf4, redD, and glnR, and single large-size gene cluster deletion, such as the antibiotic biosynthetic clusters of actinorhodin (ACT) (21.3 kb), undecylprodigiosin (RED) (31.6 kb), and Ca(2+)-dependent antibiotic (82.8 kb). Furthermore, we also realized simultaneous deletions of actII-orf4 and redD, and of the ACT and RED biosynthetic gene clusters with hi...Continue Reading

References

Nov 26, 1999·Applied Microbiology and Biotechnology·A L Demain
Jan 19, 2000·Drug Discovery Today·J M Fostel, P A Lartey
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Nov 10, 2001·Archives of Microbiology·M G WatveB D Bhole
Feb 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bertolt GustKeith F Chater
Apr 9, 2005·The Journal of Antibiotics·János Bérdy
Feb 21, 2007·Journal of Natural Products·David J Newman, Gordon M Cragg
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Jun 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Daniel W UdwaryBradley S Moore
Oct 2, 2007·Current Opinion in Biotechnology·Dagmar WirthHansjörg Hauser
Jun 6, 2008·Current Opinion in Pharmacology·Richard H Baltz
Aug 16, 2008·Science·Stan J J BrounsJohn van der Oost
Jul 15, 2009·Marine Drugs·Carlos OlanoJosé A Salas
Oct 22, 2009·Natural Product Reports·Markus NettBradley S Moore
Dec 1, 2009·Cell·Caryn R HaleMichael P Terns
Jan 9, 2010·Science·Philippe Horvath, Rodolphe Barrangou
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mamoru KomatsuHaruo Ikeda
Mar 17, 2010·Current Opinion in Microbiology·Keith E J TyoJens Nielsen
Sep 3, 2010·Acta Biochimica Et Biophysica Sinica·Zhiqun LuZhongjun Qin
Oct 12, 2010·Journal of Industrial Microbiology & Biotechnology·Olga GenilloudFrancisca Vicente
Nov 5, 2010·Nature·Josiane E GarneauSylvain Moineau
Nov 30, 2010·Current Opinion in Chemical Biology·Jaclyn M WinterChristian Hertweck
Mar 8, 2011·Microbial Biotechnology·Robin K Pettit
Apr 8, 2011·Current Pharmaceutical Biotechnology·Marimuthu JeyaJung-Kul Lee
Feb 10, 2012·Journal of Natural Products·David J Newman, Gordon M Cragg
Jun 2, 2012·Current Opinion in Biotechnology·Audrey LeprinceVitor A P Martins dos Santos
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 22, 2013·Chemical Biology & Drug Design·Daniel ScottJürgen Rohr
Jan 31, 2013·Nature Biotechnology·Wenyan JiangLuciano A Marraffini
Jan 31, 2013·Nature Biotechnology·Seung Woo ChoJin-Soo Kim
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Mar 6, 2013·Nucleic Acids Research·James E DiCarloGeorge M Church
May 10, 2013·ACS Synthetic Biology·Bijan Zakeri, Timothy K Lu
May 28, 2013·Genetics·Scott J GratzKate M O'Connor-Giles
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Aug 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·Zhonggang HouJames A Thomson
Oct 19, 2013·Nature Protocols·Matthew H LarsonLei S Qi

❮ Previous
Next ❯

Citations

Feb 14, 2016·Current Opinion in Biotechnology·Raissa Estrela, Jamie Harrison Doudna Cate
Sep 14, 2015·Journal of Industrial Microbiology & Biotechnology·Richard H Baltz
Jan 23, 2016·Frontiers in Microbiology·Ana Lúcia Leitão, Francisco J Enguita
Dec 29, 2015·Metabolic Engineering·Tadas JakočiūnasJay D Keasling
Jan 23, 2016·Scientific Reports·Carlotta RondaAlex Toftgaard Nielsen
Mar 6, 2016·Trends in Biotechnology·Ioannis MougiakosJohn van der Oost
Oct 16, 2015·Biotechnology and Bioengineering·Michelle L LuoChase L Beisel
Jul 26, 2015·Annual Review of Microbiology·Wenyan Jiang, Luciano A Marraffini
Oct 16, 2015·Nucleic Acids Research·Yingjun LiQunxin She
Sep 13, 2015·Current Opinion in Microbiology·Jason M PetersLei S Qi
Apr 10, 2016·Nucleic Acids Research·Lun Cui, David Bikard
Sep 7, 2016·Frontiers in Microbiology·Polpass Arul Jose, Bhavanath Jha
Oct 30, 2016·Metabolic Engineering·Hung LiYu-Chen Hu
Oct 9, 2016·Journal of Industrial Microbiology & Biotechnology·Yue ZhangGuang-Rong Zhao
Feb 2, 2017·ACS Synthetic Biology·Ioannis MougiakosRichard van Kranenburg
Aug 5, 2016·Scientific Reports·Krishna KannanDaniel G Gibson
Mar 10, 2017·Expert Opinion on Drug Discovery·Mingzi M ZhangHuimin Zhao
Apr 12, 2017·Nature Chemical Biology·Mingzi M ZhangHuimin Zhao
Oct 4, 2015·Nature·Luciano A Marraffini
Apr 14, 2016·Natural Product Reports·Mingzi M ZhangHuimin Zhao
Nov 18, 2017·Microbial Cell Factories·Jiao LiuYanhe Ma
May 12, 2018·Biotechnology and Bioengineering·Emily FreedCarrie A Eckert
Jun 5, 2018·Biotechnology Journal·Yawei ZhaoYinhua Lu
Jun 20, 2018·Biotechnology Journal·Katia TarasavaRyan T Gill
Jul 20, 2018·Antibiotics·Ewa Maria Musiol-Kroll, Wolfgang Wohlleben
Jul 8, 2018·Applied and Environmental Microbiology·Lei LiYinhua Lu
Jun 5, 2018·Biotechnology Journal·Takayuki ArazoeKeiji Nishida
Sep 3, 2017·Applied and Environmental Microbiology·Xin SongSheng Yang
Mar 5, 2017·Applied and Environmental Microbiology·Shaohua WangYi Wang
Apr 26, 2015·Applied and Environmental Microbiology·Tao XuJizhong Zhou
Jun 5, 2016·Applied and Environmental Microbiology·Adam W WestbrookC Perry Chou
Dec 19, 2016·F1000Research·Keith F Chater
Feb 16, 2016·Nature Reviews. Microbiology·Michael J SmanskiChristopher A Voigt
May 16, 2019·FEMS Microbiology Letters·Belén Adiego-PérezJohn van der Oost
May 16, 2019·Biotechnology and Bioengineering·Wan Lin YeoFong Tian Wong

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPRi Screens for Antibiotics

The CRISPR-Cas system is a gene editing technique that can be used for high-throughput genome-wide screens to identify modes of actions of novel antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Actinomycosis

Actinomycosis is a rare, chronic, and slowly progressive granulomatous disease caused by filamentous Gram positive anaerobic bacteria from the Actinomycetaceae family (genus Actinomyces). The disease is characterised by the formation of painful abscesses in the mouth, lungs,breast or gastrointestinal tract. Discover the latest research on actinomycosis here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.